This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Nephrogenex, Inc. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Roger E Marti: Innovator in Advanced Glycation End Products
Introduction
Roger E Marti is a notable inventor based in Winterthur, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit advanced glycation end products (AGEs). His work is crucial for addressing complications associated with AGEs and advanced lipoxidation end products (ALEs).
Latest Patents
Roger E Marti holds a patent for "Inhibitors of advanced glycation end products." This invention provides compounds of a specific formula, along with pharmaceutical compositions and methods for treating or inhibiting the development of AGE- and/or ALE-associated complications in subjects in need thereof. He has 1 patent to his name, showcasing his innovative approach to tackling health issues.
Career Highlights
Marti is currently associated with Nephrogenex, Inc., a company focused on developing therapies for kidney-related diseases. His expertise in the pharmaceutical field has allowed him to contribute to advancements that can potentially improve patient outcomes.
Collaborations
One of his notable collaborators is Raja G Khalifah, with whom he has worked on various projects related to his patent and research initiatives.
Conclusion
Roger E Marti's contributions to the field of pharmaceuticals, particularly through his patent on inhibitors of advanced glycation end products, highlight his role as an innovator. His work continues to pave the way for advancements in treating AGE- and ALE-associated complications.